FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline

Go back to FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
Profile Technologies, Inc. (NASDAQ: PRTK) Delayed: 2.23 --0 (-0%)
Previous Close $2.23    52 Week High $22.00 
Open $0.00    52 Week Low $9.80 
Day High $2.23    P/E N/A 
Day Low $2.23    EPS $-0.08 
Volume 1,940,343       

(NASDAQ: ZLAB) Delayed: 24.34 +0.31 (1.29%)
Previous Close $24.03    52 Week High $ 
Open $24.38    52 Week Low $ 
Day High $24.39    P/E N/A 
Day Low $23.02    EPS $ 
Volume 1,739,129